Skip to main content
Tessa NewsLink
Paste a health news link, or browse

Source study found

Story checked

Severe long Covid associated with distinct oral and lung microbiomes (opens in a new tab)

news-medical.net · 2026-10-11

Short answerEvidenceSource

Short answer

Mixed

Mixed.

2 claims go further than the study. 2 other points were not covered by the paper.

  • 3 supported
  • 2 overstated
  • 2 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Mixed

Two of seven claims overstate the study. Three of seven check out. Two claims the study doesn't address.

  • 3 supported
  • 2 overstated
  • 2 not covered
Open claim evidence
3

The source study

Sputum and oral microbiota profiles are associated with long COVID severity and phenotype post-hospitalisation: a UK multicentre, prospective cohort study

European Respiratory Journal · 2026
Open source record (opens in a new tab)
Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

7 claims in this story

Showing all 7 claimsChoose a verdict to focus the list.

Claim 1 of 7OverstatedThe research also found that differences in the lung microbiome were linked to respiratory symptoms, as well as the cognitive and digestive problems known to occur in long Covid.View evidenceHide evidence

Why this verdict

The paper profile supports associations between microbiota profiles and pulmonary, neurocognitive, and gastrointestinal phenotypes. However, the story specifically attributes these links to the lung microbiome, while the abstract-level profile says reduced lung function and neurocognitive symptoms were associated with distinct oral microbiota profiles, and gastrointestinal symptoms with a distinct sputum profile. The phenotype associations are real, but the body-site attribution is too broad.

1

Study evidence

The 'very severe' long COVID severity cluster (predominantly pulmonary) was associated with a distinct post-COVID-19 microbiota profile.

“Adults were prospectively recruited to the longitudinal UK Post-hospitalisation COVID-19 study (PHOSP-COVID).”
Claim 2 of 7OverstatedPeople with very severe long Covid had very obvious differences in the microbiome in their mouth and lungs compared with people who did not have severe long Covid, and some changes were linked to reduced lung function, neurocognitive symptoms, gut symptoms, and inflammatory signs in blood samples.View evidenceHide evidence

Why this verdict

The profile supports that the 'very severe' cluster had a distinct post-COVID microbiota profile, that microbiota profiles were associated with reduced lung function, neurocognitive symptoms, gastrointestinal symptoms, and that lactic acid bacteria abundance correlated with elevated plasma inflammatory proteins. However, the story's 'very obvious differences' implies a magnitude not available in the abstract-level profile, which reports no effect sizes, p-values, or strength of separation. The associations are supported, but the magnitude language outruns the evidence.

1

Study evidence

The 'very severe' long COVID severity cluster (predominantly pulmonary) was associated with a distinct post-COVID-19 microbiota profile.

“Adults were prospectively recruited to the longitudinal UK Post-hospitalisation COVID-19 study (PHOSP-COVID).”
2

Study evidence

Co-occurrence network analysis identified keystone taxa in oral and sputum microbiota from post-hospitalised COVID-19 participants.

“Co-occurrence network analysis identified keystone taxa.”
Claim 3 of 7Not coveredResearchers said their findings may shed light on why some people develop long Covid and could point to new ways to treat the condition.View evidenceHide evidence

Why this verdict

The profile supports observational microbiota associations that could be interpreted as biologically informative, but the abstract-level evidence supplied does not verify that the researchers claimed the findings could point to new treatments. No treatment testing or treatment-effect evidence is present in the supplied profile.

1

Study evidence

The 'very severe' long COVID severity cluster (predominantly pulmonary) was associated with a distinct post-COVID-19 microbiota profile.

“Adults were prospectively recruited to the longitudinal UK Post-hospitalisation COVID-19 study (PHOSP-COVID).”
2

Study evidence

Co-occurrence network analysis identified keystone taxa in oral and sputum microbiota from post-hospitalised COVID-19 participants.

“Co-occurrence network analysis identified keystone taxa.”
Claim 4 of 7Not coveredThe study included 771 people treated for Covid-19 at 38 UK hospitals, and participants were grouped by symptom severity five months after discharge.View evidenceHide evidence

As stated771 people

Why this verdict

The supplied profile supports a PHOSP-COVID UK post-hospitalisation cohort and reports 771 participants for microbiota/network analyses, with grouping by previously described severity clusters. However, the abstract-level profile does not verify the '38 UK hospitals' detail or that grouping occurred specifically at five months after discharge; the profile emphasizes microbiota sampling at six months.

1

Study evidence

The 'very severe' long COVID severity cluster (predominantly pulmonary) was associated with a distinct post-COVID-19 microbiota profile.

“Adults were prospectively recruited to the longitudinal UK Post-hospitalisation COVID-19 study (PHOSP-COVID).”
2

Study evidence

Co-occurrence network analysis identified keystone taxa in oral and sputum microbiota from post-hospitalised COVID-19 participants.

“Co-occurrence network analysis identified keystone taxa.”
Claim 5 of 7SupportedA study of more than 700 people found that people with long Covid had distinct differences in the bacteria living in their mouths and lungs.View evidenceHide evidence

As statedmore than 700 people

Why this verdict

The abstract-level profile supports a cohort of more than 700 post-hospitalised COVID-19 participants with oral and sputum microbiota profiles that differed by long-COVID severity/phenotype, including a distinct profile in the 'very severe' cluster. The headline wording is broad, but it remains framed as an association/difference rather than causation.

1

Study evidence

The 'very severe' long COVID severity cluster (predominantly pulmonary) was associated with a distinct post-COVID-19 microbiota profile.

“Adults were prospectively recruited to the longitudinal UK Post-hospitalisation COVID-19 study (PHOSP-COVID).”
Claim 6 of 7SupportedSix months after discharge, researchers collected saliva and sputum samples, used DNA sequencing to identify microbes, and compared microbiome features with patients' symptoms.View evidenceHide evidence

Why this verdict

The profile supports collection of oral rinse and sputum samples at six months post-discharge, 16S rRNA gene amplicon sequencing to identify microbiota composition, and comparisons with severity clusters and symptom subgroups. The story's 'saliva' wording is less precise than the profile's 'oral rinse,' but the methodological claim is substantially supported.

1

Study evidence

The 'very severe' long COVID severity cluster (predominantly pulmonary) was associated with a distinct post-COVID-19 microbiota profile.

“Adults were prospectively recruited to the longitudinal UK Post-hospitalisation COVID-19 study (PHOSP-COVID).”
Claim 7 of 7SupportedThe lead author said it is not known whether the microbiome changes came before Covid infection or happened afterward, and that it is also unknown how the microbiome may change in later years.View evidenceHide evidence

Why this verdict

The profile supports the core caveat that these are observational, post-hospitalisation associations at a single follow-up timepoint and cannot establish directionality or causality. The exact lead-author quotation and the specific 'later years' phrasing are not directly verifiable from the abstract-level profile, but the limitation itself is consistent with the supplied evidence.

1

Study evidence

The 'very severe' long COVID severity cluster (predominantly pulmonary) was associated with a distinct post-COVID-19 microbiota profile.

“Adults were prospectively recruited to the longitudinal UK Post-hospitalisation COVID-19 study (PHOSP-COVID).”
2

Study evidence

Lactic acid bacteria abundance was associated with elevated plasma inflammatory proteins (Spearman rank correlations).

“Associations between keystone taxa and plasma inflammatory proteins were assessed through Spearman's rank correlations.”
Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

  • Co-occurrence network analysis identified keystone taxa, with a shift toward higher prevalence of lactic acid bacteria in participants with worse health outcomes.

    The story mentions general microbiome differences but does not report the network-analysis element, keystone taxa, or the specific shift toward lactic acid bacteria.

    From Co-occurrence network analysis on 16S abundance data

6 things the story did carry across
  • Prospective PHOSP-COVID post-hospitalisation cohort with oral rinse and sputum microbiota profiled at about six months using 16S rRNA gene amplicon sequencing.
  • Main finding: long-COVID severity clusters, especially the 'very severe' cluster, were associated with distinct oral and/or sputum microbiota profiles.
  • Symptom- and phenotype-specific associations differed by body site: reduced lung function and persistent neurocognitive symptoms were associated with oral microbiota profiles, while gastrointestinal symptoms were associated with sputum microbiota profiles.
  • Lactic acid bacteria abundance was associated with elevated plasma inflammatory proteins, based on Spearman rank correlations.
  • Observational, single-timepoint post-discharge associations cannot establish causality or whether microbiome differences preceded COVID-19 infection or resulted from it.
  • The study provides no treatment-effect evidence; any treatment implications are speculative and future-oriented.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

3

Evidence read

study summary

Lead result

human in vivo

1Lead resulthuman in vivoCharacterise oral and sputum microbiota composition (diversity and overall profiles) at 6 months post-discharge and test associations with long COVID severity clusters, symptom subgroups, and pulmonary function.prospective multicentre cohortExpand

In plain English

In a prospective multicentre cohort (PHOSP-COVID), oral rinse and sputum microbiota were profiled by 16S rRNA gene amplicon sequencing at 6 months post-hospital discharge and compared across predefined long COVID severity clusters, symptom subgroups, and pulmonary function measurements to assess associations between microbiota composition/diversity and long COVID severity and phenotype.

Key findings

  • The 'very severe' long COVID severity cluster (predominantly pulmonary) was associated with a distinct post-COVID-19 microbiota profile.
  • Reduced lung function was associated with a distinct oral microbiota profile at 6 months post-discharge.
“Adults were prospectively recruited to the longitudinal UK Post-hospitalisation COVID-19 study (PHOSP-COVID).”
2human in vivoIdentify microbiota co-occurrence network structure and keystone taxa, and evaluate whether keystone taxa shift with worse long COVID health outcomes (e.g., toward lactic acid bacteria).Co-occurrence network analysis on 16S abundance dataExpand

In plain English

In a prospective post-hospitalisation cohort, authors performed co-occurrence network analysis on 16S rRNA gene amplicon-derived microbiota data from oral rinses and sputum collected ~6 months after discharge (771 participants assessed). Networks were used to identify keystone taxa; authors report that keystone taxa composition shifted with worse long COVID health outcomes, with a higher prevalence of lactic acid bacteria among keystone taxa in participants with poorer outcomes. Lactic acid bacteria abundance was also reported to correlate with elevated plasma inflammatory proteins (Spearman correlations).

Key findings

  • Co-occurrence network analysis identified keystone taxa in oral and sputum microbiota from post-hospitalised COVID-19 participants.
  • Keystone taxa composition shifted toward a higher prevalence of lactic acid bacteria in participants with worse long COVID health outcomes (severity clusters/phenotypes).
“Co-occurrence network analysis identified keystone taxa.”
3human in vivoTest associations between microbiota keystone taxa (including lactic acid bacteria abundance) and systemic inflammation measured as plasma inflammatory proteins.correlation analysisExpand

In plain English

In a subset of the PHOSP-COVID cohort, abundance of microbiota keystone taxa — notably lactic acid bacteria — was correlated with systemic inflammation: lactic acid bacteria abundance was associated with elevated plasma inflammatory proteins, assessed using Spearman's rank correlations.

Key findings

  • Lactic acid bacteria abundance was associated with elevated plasma inflammatory proteins (Spearman rank correlations).
“Associations between keystone taxa and plasma inflammatory proteins were assessed through Spearman's rank correlations.”
What this piece can’t prove
  • Observational, cross-sectional association (from samples taken post-hospitalisation) — cannot determine directionality or causality.

2 further details could not be confirmed from the summary.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Open the paper in Tessa

Sputum and oral microbiota profiles are associated with long COVID severity and phenotype post-hospitalisation: a UK multicentre, prospective cohort study

European Respiratory Journal · 2026

Source record (opens in a new tab)

Why this one

Near certain

NewsLink found the paper. Tessa is where you inspect it deeply.

Papers considered

The selected paper, plus nearby candidates.

Crossref, PubMed · 37 candidate papers

Selected

Sputum and oral microbiota profiles are associated with long COVID severity and phenotype post-hospitalisation: a UK multicentre, prospective cohort study

European Respiratory Journal · 2026 · Crossref

Source (opens in a new tab)
Candidate

Rapid molecular detection of respiratory pathogens in patients with bronchiectasis

ERJ Open Research · 2026 · Crossref

Source (opens in a new tab)
Candidate

Simultaneous measurement of 16S-rRNA and pre-16S-rRNA as a strategy to monitor clinical tuberculosis

Frontiers in Antibiotics · 2026 · Crossref

Source (opens in a new tab)
Candidate

Reply to Tang and Sun, and to Deng and Liu

American Journal of Respiratory and Critical Care Medicine · 2026 · Crossref

Source (opens in a new tab)
Candidate

The European Respiratory Journal 2026: towards the golden age of respiratory science?

European Respiratory Journal · 2026 · Crossref

Source (opens in a new tab)

And 31 more candidates considered.